ACTU · Actuate Therapeutics, Inc.
$1.18
-0.08 (-6.35%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$28.23M
Shares
23.93M
Actuate Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Actuate Therapeutics, Inc. (ACTU) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
12 filings
12 filers
Visit website
Investor relations